Conversely, in accelerated phase/blastic phase (AP/BP) CML patients, increased ABCG2 (drug pump, ATP-binding cassette sub-family G member 2) expression was associated with the lack of PTEN protein and subsequent Akt activation [117]. The gene discussed is PTEN; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.